AIHTA - Publications - Search - Olaparib (Lynparza®) plus bevacizumab as first-line maintenance treatment in patients with ovarian cancer

Grössmann, N. (2020): Olaparib (Lynparza®) plus bevacizumab as first-line maintenance treatment in patients with ovarian cancer. Oncology Fact Sheet Nr. 24.

[thumbnail of Oncology Fact Sheet Nr.24.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
95kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WP Gynaecology > WP 440-468 Uterine diseases
Language:English
Series Name:Oncology Fact Sheet Nr. 24
Deposited on:29 Oct 2020 12:39
Last Modified:29 Oct 2020 12:39

Repository Staff Only: item control page